BioHarvest Sciences (BHST) to Release Quarterly Earnings on Thursday

BioHarvest Sciences (NASDAQ:BHST) is expected to be posting its Q3 2025 results after the market closes on Thursday, November 13th. Analysts expect BioHarvest Sciences to post earnings of ($0.14) per share and revenue of $9.1110 million for the quarter. Investors can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, November 13, 2025 at 4:30 PM ET.

BioHarvest Sciences (NASDAQ:BHST) last released its earnings results on Monday, August 11th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.04). The business had revenue of $8.52 million during the quarter, compared to the consensus estimate of $8.53 million. BioHarvest Sciences had a negative net margin of 39.95% and a negative return on equity of 11,357.84%. On average, analysts expect BioHarvest Sciences to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

BioHarvest Sciences Trading Up 2.5%

Shares of BioHarvest Sciences stock opened at $7.31 on Tuesday. The business’s fifty day simple moving average is $9.71 and its 200 day simple moving average is $8.12. BioHarvest Sciences has a 12 month low of $4.72 and a 12 month high of $12.80. The firm has a market capitalization of $120.03 million, a P/E ratio of -10.44 and a beta of 0.76.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on BHST shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BioHarvest Sciences in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of BioHarvest Sciences to a “hold” rating in a report on Saturday, October 18th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $13.67.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.